Tony Brampton
Directeur/Membre du Conseil chez Brody House Management Ltd.
Profil
Anthony David Brampton is currently an Independent Director at Origin Life Sciences, Inc., a Director at Brody House Management Ltd., a Director at LCIP 2012 LLP, a Director at Origin Life Sciences Ltd., an Investment Partner at Longbow Capital LLP, and a Partner at Sudbrook Associates LLP.
He previously served as an Independent Non-Executive Director at Polar Capital Global Healthcare Trust Plc, a Managing Director-Finance at JPMorgan Cazenove Ltd., a Non-Executive Director at Domainex Ltd.
and PolyTherics Ltd., a Director at iPulse Ltd., and a Non-Executive Director at Abzena Ltd.
He was also a Director at PCGH ZDP Plc and an Analyst at TD Asset Administration UK Ltd.
Brampton received his undergraduate and graduate degrees from the University of Oxford.
Postes actifs de Tony Brampton
| Sociétés | Poste | Début |
|---|---|---|
| Sudbrook Associates LLP | Corporate Officer/Principal | - |
| Brody House Management Ltd. | Directeur/Membre du Conseil | - |
| LCIP 2012 LLP | Directeur/Membre du Conseil | - |
Longbow Capital LLP
 Longbow Capital LLP Investment ManagersFinance Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom. | Analyste en capital-investissement | 21/05/2014 |
Origin Life Sciences, Inc.
 Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 01/09/2014 |
Origin Life Sciences Ltd.
 Origin Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Origin Life Sciences, Inc., Origin Life Sciences Ltd. engages in conducting research in biotechnology. The company is based in London, UK. | Directeur/Membre du Conseil | 01/01/2015 |
Anciens postes connus de Tony Brampton
| Sociétés | Poste | Fin |
|---|---|---|
PCGH ZDP Plc
 PCGH ZDP Plc Investment Trusts/Mutual FundsMiscellaneous PCGH ZDP Plc is a closed-end investment fund. It generates capital growth by investing in a global portfolio of healthcare stocks across all healthcare sectors. The company was founded March 30, 2017 and was headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 26/02/2020 |
| POLAR CAPITAL GLOBAL HEALTHCARE TRUST PLC | Directeur/Membre du Conseil | 26/02/2020 |
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Président | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Tony Brampton
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Polar Capital Global Healthcare Trust Plc
 Polar Capital Global Healthcare Trust Plc Investment Trusts/Mutual FundsMiscellaneous Polar Capital Global Healthcare Trust Plc is an investment company. Its portfolio includes healthcare stocks across all four healthcare sub-sectors. The company was founded on May 12, 2010 and is headquartered in London, the United Kingdom. | Miscellaneous |
Origin Life Sciences, Inc.
Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | Health Technology |
| Cazenove & Co. Ltd. | Finance |
TD Asset Administration UK Ltd.
 TD Asset Administration UK Ltd. Investment Banks/BrokersFinance TD Asset Administration UK Ltd. provides securities brokerage and fund management services. TD Asset Administration UK Ltd. is based in London, UK. | Finance |
JPMorgan Cazenove Ltd.
 JPMorgan Cazenove Ltd. Investment Banks/BrokersFinance J.P. Morgan Cazenove Ltd. (JPMC) is jointly owned by JPMorgan and Cazenove Group Ltd. Headquartered in London, JPMC has offices in Hong Kong, Beijing, Singapore, Frankfurt, Paris and New York as well as access to JPMorgan's global network. The firm provides a full range of investment banking services, including financial advice, M&A, investor relations, debt and equity capital markets advice and execution and equity research and distribution. The Equities business forms an important part of the Investment Banking division. JPMC analysts cover the major stocks in all areas of specialisation across the UK, Europe and Asia ex-Japan | Finance |
Longbow Capital LLP
Longbow Capital LLP Investment ManagersFinance Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom. | Finance |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Health Technology |
| Sudbrook Associates LLP | |
iPulse Ltd.
 iPulse Ltd. Medical SpecialtiesHealth Technology iPulse Ltd. engages in the manufacture of medical and dental instruments. The company was founded on November 23, 2012 and is headquartered in Swansea, the United Kingdom. | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Brody House Management Ltd. | |
| LCIP 2012 LLP | |
PCGH ZDP Plc
PCGH ZDP Plc Investment Trusts/Mutual FundsMiscellaneous PCGH ZDP Plc is a closed-end investment fund. It generates capital growth by investing in a global portfolio of healthcare stocks across all healthcare sectors. The company was founded March 30, 2017 and was headquartered in London, the United Kingdom. | Miscellaneous |
Origin Life Sciences Ltd.
Origin Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Origin Life Sciences, Inc., Origin Life Sciences Ltd. engages in conducting research in biotechnology. The company is based in London, UK. | Commercial Services |
